Are you actually considering voting Dempocrat this November?
Yes, specifically for a progressive. I'm not interested in more neoliberal zionism, but "make stuff cheaper" is a good policy.
The choice is easy.
2028 too
>>544084933hes holding that tray up with his dickimpressive
>>544085013good goy
>>544084933They both have Jewish handler sex partners
>>544085021>white “liberals”>HEY YOU HECKIN NAZIS YOU BETTER GET WITH THE PROGRAM WE NIGGER LOVERS NOWgee i cant wait
>>544084933Yes absolutely.Give me one reason not to.
>>544084933Yes. I know what will happen if they win but I don't care at this point. There is nothing left to save. Might as well speed run to collapse and start over.
>>544084933Oh I am way beyond "considering" it.
>>544085084you cant do that?
>>544084933having been born before 2008, the answer to that question is: there are no circumstances whatsoeverunder which i would cast a vote for any democratin any electionever
>>544085561thats gotta be a 30 pound turkey + tray resting on his knob, come on give him his props.
>>544084933Nope. Not voting. Both are gay and jewish.
>>544085021Wow, Amy has nice feet
>>544087869Vote Amy!
>>544085021why the fuck Is this subhuman hindushit raperat not wearing shoes during an interview
>>544084933I have never voted and I never will.I just watch you fags argue as the world becomes more hellish and the invisible aristocracy becomes more godlike every passing day.If you've seen the UFOs, you know this shit is all a puppet show.
>>544084933>checked
lol no. No one but shills who aren't even American are "voting" for demoshits this election. I know plenty of former demoshits though.
>>544084933DemonCrats will not win any shitToo early for anything of that>>544091056meds
>>544091056>The company was Axovant Sciences, founded by Ramaswamy in 2014 as part of his pharmaceutical business Roivant Sciences.>He acquired a failed Alzheimer's drug. GlaxoSmithKline had already tested the drug, later called intepirdine, in trials that failed to meet key objectives. Axovant acquired the rights for about $5 million.>His mother helped reanalyse the trial data. Geetha Ramaswamy, a physician employed by Axovant, co-authored analyses that presented more favourable results by examining selected groups of patients and alternative measures. Critics argued that these methods made the drug look more promising than the original results justified.>Axovant raised hundreds of millions of dollars. Its 2015 IPO raised approximately $315 million, with investors buying into the possibility that the drug could treat Alzheimer's disease.>Ramaswamy made millions while investors later suffered losses. Reporting based on his financial records says he realised roughly $38–40 million in gains from stock sales around that period. In 2017, the drug failed a major Phase 3 trial and Axovant's share price collapsed.
>>544084933
>>544084933I don’t vote for pedophiles
